Diagnostic Gleason score and castration-resistant prostate cancer.

about

Diagnostic Gleason score and castration-resistant prostate cancer.

Item

http://www.wikidata.org/entity/Q53789514

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Diagnostic Gleason score and castration-resistant prostate cancer.

@en

Diagnostic Gleason score and castration-resistant prostate cancer.

@nl

type

Item

label

Diagnostic Gleason score and castration-resistant prostate cancer.

@en

Diagnostic Gleason score and castration-resistant prostate cancer.

@nl

prefLabel

Diagnostic Gleason score and castration-resistant prostate cancer.

@en

Diagnostic Gleason score and castration-resistant prostate cancer.

@nl

P1476

Diagnostic Gleason score and castration-resistant prostate cancer.

@en

P2093

A Jayaram

http://www.w3.org/2001/XMLSchema#string

P2860

Integrative clinical genomics of advanced prostate cancer.

Increased survival with enzalutamide in prostate cancer after chemotherapy

Abiraterone and increased survival in metastatic prostate cancer

Initial biopsy Gleason score as a predictive marker for survival benefit in patients with castration-resistant prostate cancer treated with docetaxel: data from the TAX327 study.

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials.

Enzalutamide in metastatic prostate cancer before chemotherapy.

Circulating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancer

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.

Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate.

P304

962-964

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/ANNONC/MDW179

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gerhardt Attard

P577

2016-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

301483020

http://www.w3.org/2001/XMLSchema#string

P698

27091809

http://www.w3.org/2001/XMLSchema#string